{"nct_id":"NCT01431547","title":"Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)","status":"COMPLETED","status_verified_date":"2016-06","start_date":"2012-02","start_date_type":null,"primary_completion_date":"2013-09","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}